By continuing to use our site, you consent to the processing of cookies, user data (location information, type and version of the OS, the type and version of the browser, the type of device and the resolution of its screen, the source of where the user came from, from which site or for what advertisement, language OS and Browser, which pages are opened and to which buttons the user presses, ip-address) for the purpose of site functioning, retargeting and statistical surveys and reviews. If you do not want your data to be processed, please leave the site.
The Voice of People With Breast Cancer
Physicians
Learning Activity: From a Maze to Amazed! Navigating breast cancer therapies and treatment toxicities in family practice
Program Description
Family Physicians are playing an increasingly important role in the care of patients with breast cancer throughout their cancer journeys and beyond. Breast cancer treatment strategies continue to evolve rapidly. Oral agents are standard of care options for both early-stage and metastatic hormone-sensitive breast cancer. Early recognition and management of drug-related toxicities are imperative for optimizing breast cancer outcomes. This program aims to review general breast cancer treatment strategies, with a focus on oral agents, and will explore the management of toxicities that may be encountered in family practice.
Program developed: May 2025
Learning Objectives
Upon completion of this activity, participants should be able to:
- Recognize therapies used in the management of hormone-sensitive breast cancer, including endocrine therapies and targeted therapies
- Implement strategies to recognize and facilitate the management of common toxicities and rare but serious toxicities with oral therapies
- Understand the role of the family physician within the spectrum of care for patients with breast cancer
Faculty and Disclosures
Peter Lin, MD, CCFP
Director Primary Care Initiatives, Canadian Heart Research Centre
Toronto, Ontario
Sandeep Sehdev, MD, FRCPC
Medical Oncology
Ottawa Hospital Cancer Center
Ottawa, Ontario
Moira Rushton, MD, MPH, FRCPC
Medical OncologistOttawa Hospital Cancer Center
Ottawa, Ontario
Anna Wilkinson, MD, CCFP
Family Medicine
Ottawa Hospital Cancer Center
Ottawa, Ontario
|
|
|
|
Funding Support
This CPD Network initiative is non-accredited and is supported by a grant from AstraZeneca Canada. In compliance with the Innovative Medicines Canada Code of Ethical Practices, the content of this program is intended for Healthcare Professionals only.
Access the Program
“From a Maze to Amazed! Navigating breast cancer therapies and treatment toxicities in family practice” is a 60-slide PowerPoint slide program with a 2-page companion handout, designed for a Family Physician audience. We invite healthcare professionals to access the materials using the link below.
NOT MEDICAL ADVICE
CBCN and its suppliers do not assume any legal liability or responsibility for the accuracy, completeness or usefulness of any information, drugs, therapies, treatments, products, processes, or services appearing on this Site. All content provided on this Site is provided for informational purposes only. This Site does not provide medical advice, diagnosis or treatment. The Site and its services are not a substitute for professional medical advice and treatment.
SHARE
Our Stories
-
Sep 9, 2025, 12:00 AM -
-
Aug 26, 2025, 12:00 AM
Receive updates by email Subscribe Now
About CBCN
CBCN strives to voice the views and concerns of breast cancer patients through education, advocacy activities, and the promotion of information sharing.
Canadian Breast Cancer Network
185 Somerset St. West Suite 318, Ottawa, ON Canada K2P 0J2
Tel: 613-230-3044
Toll-free: 1-800-685-8820
Email Us
